Does CERTOLIZUMAB PEGOL Cause Injection site discolouration? 597 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 597 reports of Injection site discolouration have been filed in association with CERTOLIZUMAB PEGOL (Cimzia). This represents 0.6% of all adverse event reports for CERTOLIZUMAB PEGOL.
597
Reports of Injection site discolouration with CERTOLIZUMAB PEGOL
0.6%
of all CERTOLIZUMAB PEGOL reports
1
Deaths
44
Hospitalizations
How Dangerous Is Injection site discolouration From CERTOLIZUMAB PEGOL?
Of the 597 reports, 1 (0.2%) resulted in death, 44 (7.4%) required hospitalization, and 3 (0.5%) were considered life-threatening.
Is Injection site discolouration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CERTOLIZUMAB PEGOL. However, 597 reports have been filed with the FAERS database.
What Other Side Effects Does CERTOLIZUMAB PEGOL Cause?
Drug ineffective (23,838)
Rheumatoid arthritis (17,782)
Pain (13,929)
Fatigue (11,438)
Off label use (10,281)
Rash (9,663)
Alopecia (9,111)
Maternal exposure during pregnancy (9,013)
Arthralgia (8,993)
Abdominal discomfort (8,615)
What Other Drugs Cause Injection site discolouration?
ETANERCEPT (1,846)
DUPILUMAB (779)
ADALIMUMAB (554)
EVOLOCUMAB (476)
GLATIRAMER (270)
EXENATIDE (266)
TERIPARATIDE (249)
ASFOTASE ALFA (243)
ENBREL (231)
INSULIN GLARGINE (169)
Which CERTOLIZUMAB PEGOL Alternatives Have Lower Injection site discolouration Risk?
CERTOLIZUMAB PEGOL vs CERTOPARIN
CERTOLIZUMAB PEGOL vs CETIRIZINE
CERTOLIZUMAB PEGOL vs CETIRIZINE\PSEUDOEPHEDRINE
CERTOLIZUMAB PEGOL vs CETRIMIDE
CERTOLIZUMAB PEGOL vs CETRORELIX